Jubilant Ingrevia Limited announced its Q3 FY26 results, with total revenue from operations at ₹320.97 crore. The company reported a profit before tax of ₹25.8 crore and net profit of ₹19.14 crore for the nine months ended December 31, 2025. The Board declared an interim dividend of ₹2.5 per share. The company’s Q3 performance reflects resilience amidst changing economic conditions and strategic focus on key business segments.
Financial Performance Highlights
Jubilant Ingrevia Limited reported a total revenue from operations of ₹320.97 crore for the nine months ended December 31, 2025. This represents a slight increase compared to the corresponding period last year. The profit before tax for the period stood at ₹25.8 crore, showcasing the company’s ability to maintain profitability.
Segmental Performance
The Speciality Chemicals segment continues to be a significant contributor to the overall revenue, with ₹161.06 crore in revenue. Nutrition & Health Solutions generated ₹56.03 crore, while Chemical Intermediates contributed ₹123.34 crore. These figures reflect the strategic importance of diversified business segments.
Dividend Announcement
The Board of Directors has declared an interim dividend of ₹2.5 per share (face value of ₹1 each). This decision highlights the company’s commitment to returning value to its shareholders. This interim dividend payment totals ₹3982 lakhs.
Exceptional Items
The company recognized an exceptional item related to the New Labour Codes, resulting in an additional employee benefit expense of ₹1304 lakhs for the quarter. This expense impacts the overall profitability for the period.
Key Financial Ratios
The debt-equity ratio stood at 0.18 times, indicating a conservative capital structure. Key financial ratios such as Debt service coverage ratio stood at 3.64.
Source: BSE
